Vivo Capital’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $31.7M | Buy |
3,126,604
+1,046,154
| +50% | +$10.6M | 3.25% | 6 |
|
2025
Q1 | $11.6M | Buy |
2,080,450
+802,632
| +63% | +$4.48M | 1.54% | 11 |
|
2024
Q4 | $10.3M | Hold |
1,277,818
| – | – | 1.16% | 19 |
|
2024
Q3 | $13.1M | Buy |
1,277,818
+8,142
| +0.6% | +$83.5K | 1.08% | 18 |
|
2024
Q2 | $8.98M | Buy |
1,269,676
+419,995
| +49% | +$2.97M | 0.83% | 23 |
|
2024
Q1 | $11.7M | Hold |
849,681
| – | – | 0.92% | 24 |
|
2023
Q4 | $7.82M | Buy |
849,681
+71,737
| +9% | +$660K | 0.64% | 31 |
|
2023
Q3 | $4.71M | Buy |
+777,944
| New | +$4.71M | 0.52% | 36 |
|